BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16791472)

  • 1. Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex sensors: effect of subchronic clorgyline pretreatment.
    Kitanaka N; Kitanaka J; Tatsuta T; Watabe K; Morita Y; Takemura M
    Neurochem Res; 2006 Jun; 31(6):805-13. PubMed ID: 16791472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats.
    Kitanaka N; Kitanaka J; Watabe K; Takemura M
    Neuroscience; 2010 Feb; 165(4):1370-6. PubMed ID: 19958817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
    Kitanaka N; Kitanaka J; Takemura M
    Neuroscience; 2005; 130(2):295-308. PubMed ID: 15664686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated clorgyline treatment inhibits methamphetamine-induced behavioral sensitization in mice.
    Kitanaka N; Kitanaka J; Takemura M
    Neurochem Res; 2005 Apr; 30(4):445-51. PubMed ID: 16076014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
    Sun L; Song R; Chen Y; Yang RF; Wu N; Su RB; Li J
    Acta Pharmacol Sin; 2016 Feb; 37(2):157-65. PubMed ID: 26687935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
    Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
    Neurochem Res; 2005 Nov; 30(11):1377-85. PubMed ID: 16341934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of methamphetamine-induced conditioned place preference in weaver mutant mice.
    Ikekubo Y; Ide S; Hagino Y; Ikeda K
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):324-331. PubMed ID: 32812711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.
    Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Shen L; Noda Y; Furukawa S; Nabeshima T
    Biol Psychiatry; 2007 Apr; 61(7):890-901. PubMed ID: 17046726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
    Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
    Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol enhanced the development of sensitization to the expression of methamphetamine-induced conditioned place preference in male rats.
    Khanegheini A; Khani M; Zarrabian S; Yousefzadeh-Chabok S; Taleghani BK; Haghparast A
    J Psychiatr Res; 2021 May; 137():260-265. PubMed ID: 33725638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated restraint stress reduces the acquisition and relapse of methamphetamine-conditioned place preference but not behavioral sensitization.
    Seo JY; Ko YH; Ma SX; Lee BR; Lee SY; Jang CG
    Brain Res Bull; 2018 May; 139():99-104. PubMed ID: 29421246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methanolic extract of Morinda citrifolia Linn. unripe fruit attenuates methamphetamine-induced conditioned place preferences in mice.
    Pandy V; Wai YC; Amira Roslan NF; Sajat A; Abdulla Jallb AH; Vijeepallam K
    Biomed Pharmacother; 2018 Nov; 107():368-373. PubMed ID: 30099340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats.
    Bayat AH; Haghparast A
    Pharmacol Biochem Behav; 2015 Jan; 128():8-13. PubMed ID: 25444864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice.
    Fujita Y; Kunitachi S; Iyo M; Hashimoto K
    Pharmacol Biochem Behav; 2012 Apr; 101(2):303-6. PubMed ID: 22260872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral power and theta-gamma coupling in the basolateral amygdala related with methamphetamine conditioned place preference in mice.
    Nukitram J; Cheaha D; Kumarnsit E
    Neurosci Lett; 2021 Jun; 756():135939. PubMed ID: 33945805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor.
    Kitanaka N; Kitanaka J; Takemura M
    Neurochem Res; 2006 Jun; 31(6):829-37. PubMed ID: 16794857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine 2A receptors modulate reward behaviours for methamphetamine.
    Chesworth R; Brown RM; Kim JH; Ledent C; Lawrence AJ
    Addict Biol; 2016 Mar; 21(2):407-21. PubMed ID: 25612195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel molecule "shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference.
    Niwa M; Nitta A; Mizoguchi H; Ito Y; Noda Y; Nagai T; Nabeshima T
    J Neurosci; 2007 Jul; 27(28):7604-15. PubMed ID: 17626222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C; Anderson KL; Itzhak Y
    Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.